Tepezza Hearing Loss Lawsuits Continue to Grow
The number of lawsuits filed against Horizon Therapeutics, the maker of Tepezza, for causing hearing loss continues to grow. The drug, which is used to treat thyroid eye disease, has been linked to hearing loss in some patients.
The first Tepezza hearing loss lawsuit was filed in August 2022. Since then, more than 20 lawsuits have been filed. The plaintiffs in these lawsuits allege that Horizon failed to adequately warn them about the risk of hearing loss associated with Tepezza.
In some cases, the plaintiffs have suffered permanent hearing loss. Others have experienced tinnitus, or ringing in the ears. The plaintiffs are seeking damages for their injuries, as well as compensation for medical expenses and lost wages.
Horizon has denied the allegations in the lawsuits. The company has said that Tepezza is safe and effective when used as directed. However, the company has also said that it is committed to working with patients who have experienced hearing loss after taking Tepezza.
The Tepezza hearing loss lawsuits are still in the early stages. It is not yet clear how many lawsuits will be filed or how much compensation the plaintiffs will receive. However, the lawsuits are likely to continue to grow as more patients become aware of the potential risks of Tepezza.
In addition to the lawsuits, the U.S. Food and Drug Administration (FDA) is also investigating the link between Tepezza and hearing loss. The FDA has asked Horizon to provide more information about the drug's safety profile.
The Tepezza hearing loss lawsuits are a reminder of the importance of being aware of the potential risks of any medication. If you are considering taking Tepezza, talk to your doctor about the risks and benefits of the drug.